139 related articles for article (PubMed ID: 31520578)
21. Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance.
Motte E; Le Stunff C; Briet C; Dumaz N; Silve C
Mol Cell Endocrinol; 2017 Feb; 442():1-11. PubMed ID: 27908835
[TBL] [Abstract][Full Text] [Related]
22. Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex.
Rhayem Y; Le Stunff C; Abdel Khalek W; Auzan C; Bertherat J; Linglart A; Couvineau A; Silve C; Clauser E
J Biol Chem; 2015 Nov; 290(46):27816-28. PubMed ID: 26405036
[TBL] [Abstract][Full Text] [Related]
23. [Respiratory impairment in a patient with acrodysostosis: A rare association of an uncommon pathology].
Sierrasesúmaga Martín P; Berrade Zubiri S; Chueca Guindulain MJ; Viguria N; Moreno-Galarraga L
Arch Argent Pediatr; 2021 Aug; 119(4):e340-e344. PubMed ID: 34309314
[TBL] [Abstract][Full Text] [Related]
24. Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis.
Le Stunff C; Tilotta F; Sadoine J; Le Denmat D; Briet C; Motte E; Clauser E; Bougnères P; Chaussain C; Silve C
J Bone Miner Res; 2017 Feb; 32(2):333-346. PubMed ID: 27589370
[TBL] [Abstract][Full Text] [Related]
25. Acrodysostosis: A new form of pseudohypoparathyroidism?
Silve C
Ann Endocrinol (Paris); 2015 May; 76(2):110-2. PubMed ID: 25890446
[No Abstract] [Full Text] [Related]
26. Fourteen-year follow-up of a child with acroscyphodysplasia with emphasis on the need for multidisciplinary management: a case report.
Kartalias K; Gillies AP; Peña MT; Estrada A; Bulas DI; Ferreira CR; Tosi LL
BMC Med Genet; 2020 Sep; 21(1):189. PubMed ID: 32993552
[TBL] [Abstract][Full Text] [Related]
27. Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.
Elli FM; Bordogna P; de Sanctis L; Giachero F; Verrua E; Segni M; Mazzanti L; Boldrin V; Toromanovic A; Spada A; Mantovani G
J Bone Miner Res; 2016 Jun; 31(6):1215-24. PubMed ID: 26763073
[TBL] [Abstract][Full Text] [Related]
28. Acrodysostosis.
Silve C; Clauser E; Linglart A
Horm Metab Res; 2012 Sep; 44(10):749-58. PubMed ID: 22815067
[TBL] [Abstract][Full Text] [Related]
29. Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.
Mantovani G; Spada A; Elli FM
Nat Rev Endocrinol; 2016 Jun; 12(6):347-56. PubMed ID: 27109785
[TBL] [Abstract][Full Text] [Related]
30. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.
Linglart A; Menguy C; Couvineau A; Auzan C; Gunes Y; Cancel M; Motte E; Pinto G; Chanson P; Bougnères P; Clauser E; Silve C
N Engl J Med; 2011 Jun; 364(23):2218-26. PubMed ID: 21651393
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs).
Elli FM; Pereda A; Linglart A; Perez de Nanclares G; Mantovani G
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):941-954. PubMed ID: 30665554
[TBL] [Abstract][Full Text] [Related]
32. Identification of a de novo heterozygous missense FLNB mutation in lethal atelosteogenesis type I by exome sequencing.
Jeon GW; Lee MN; Jung JM; Hong SY; Kim YN; Sin JB; Ki CS
Ann Lab Med; 2014 Mar; 34(2):134-8. PubMed ID: 24624349
[TBL] [Abstract][Full Text] [Related]
33. Inactivating PTH/PTHrP Signaling Disorders.
Mantovani G; Elli FM
Front Horm Res; 2019; 51():147-159. PubMed ID: 30641531
[TBL] [Abstract][Full Text] [Related]
34. A novel COL2A1 mutation causing spondyloepiphyseal dysplasia congenita in a Chinese family.
Zhou T; Yang X; Chen Z; Zhou Y; Cao X; Zhao C; Zhao J
J Clin Lab Anal; 2021 Apr; 35(4):e23728. PubMed ID: 33590889
[TBL] [Abstract][Full Text] [Related]
35. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
36. A heterozygous point mutation of the ANKRD11 (c.2579C>T) in a Chinese patient with idiopathic short stature.
Kang Y; He D; Li Y; Zhang Y; Shao Q; Zhang M; Ban B
Mol Genet Genomic Med; 2019 Dec; 7(12):e988. PubMed ID: 31566922
[TBL] [Abstract][Full Text] [Related]
37. Novel compound heterozygous mutations in the OTOF Gene identified by whole-exome sequencing in auditory neuropathy spectrum disorder.
Tang F; Ma D; Wang Y; Qiu Y; Liu F; Wang Q; Lu Q; Shi M; Xu L; Liu M; Liang J
BMC Med Genet; 2017 Mar; 18(1):35. PubMed ID: 28335750
[TBL] [Abstract][Full Text] [Related]
38. Association study of the PDE4D gene and obsessive-compulsive disorder in a Chinese Han population.
Huang X; Zhang J; Liu J; Zhang X
Psychiatr Genet; 2019 Dec; 29(6):226-231. PubMed ID: 31469783
[TBL] [Abstract][Full Text] [Related]
39. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
[TBL] [Abstract][Full Text] [Related]
40. Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4.
Cedervall P; Aulabaugh A; Geoghegan KF; McLellan TJ; Pandit J
Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1414-22. PubMed ID: 25775568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
